![Joseph Manhede](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Joseph Manhede
Comptroller/Controller/Auditor at
ROCKET PHARMACEUTICALS, INC.
Net worth: 179 810 $ as of 30/06/2026
Profile
Joseph Manhede is Chief Accounting Officer at Rocket Pharmaceuticals, Inc. since 2026.
Formerly, Mr. Manhede was Vice President & Financial Controller at Outlook Therapeutics, Inc. Mr. Manhede earned an MBA from Holy Family University.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 08/07/2026 | 52,576 ( 0.05% ) | 179 810 $ | 30/06/2026 |
Joseph Manhede active positions
| Companies | Position | Start |
|---|---|---|
| ROCKET PHARMACEUTICALS, INC. | Comptroller/Controller/Auditor | 01/04/2026 |
Former positions of Joseph Manhede
| Companies | Position | End |
|---|---|---|
| OUTLOOK THERAPEUTICS, INC. | Corporate Officer/Principal | - |
Training of Joseph Manhede
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
7
1st degree connections
3
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 3 |
|---|---|
Holy Family University
 Holy Family University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Outlook Therapeutics, Inc.
 Outlook Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures bevacizumab therapeutic products | Health Technology |
Rocket Pharmaceuticals, Inc.
 Rocket Pharmaceuticals, Inc. BiotechnologyHealth Technology Provides gene therapy services | Health Technology |
- Stock Market
- Insiders
- Joseph Manhede
